@article{c08b198a07a746dd8342a2b180e7e3bd,
title = "Setting the stage for the next step in cardiac amyloidosis imaging: Serial quantitative studies to assess disease activity",
author = "Prem Soman and Ahmad Masri",
note = "Funding Information: Dr. Prem Soman has served on the advisory board of Alnylam Pharmaceuticals. Dr. Masri has no conflicts of interest to report. See related article, doi:10.1007/s12350-017-0799-x.",
year = "2018",
month = oct,
day = "1",
doi = "10.1007/s12350-017-0846-7",
language = "English (US)",
volume = "25",
pages = "1571--1573",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "5",
}